Topotecan Hydrochloride
规格
119413-54-6CAS 号
601-607-9EC 号
(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;hydrochlorideIUPAC 名称
C23H24ClN3O5化学式
457.9 g/mol分子量
TOPOTECAN HYDROCHLORIDE; 119413-54-6; Topotecan Hcl; Nogitecan hydrochloride; Evotopin; Topotecan teva; Topotecan Actavis; Topotecan Hospira; SK&F S-104864-A; potactasol; DTXSID1045952; SK&F-S-104864-A; Topotecan (as hydrochloride); NSC-759263; 956S425ZCY; DTXCID9025952; SK-S-104864-A; Hydrochloride, Nogitecan; Hydrochloride, Topotecan; RefChem:57198; topotecan hydrochloride (oral); Topotecan Monohydrochloride, (S)-; SKF S-104864-A; (S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7) indolizino(1,2-b) quinoline-3,14-(4H,12H)-dione Monohydrochloride; Hycamtin; Topotecan (Hydrochloride); Topotecan monohydrochloride; Topotecan hydrochloride [USAN]; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[l,2-b]quinoline-3,14(4H,12H)-dione monohydrochloride; MFCD00866235; C23H24ClN3O5; SKF-104864A; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione monohydrochloride; (S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; NCGC00095189-01; Hycamtin (TN); SKF 104864A; NSC 609669; 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-, monohydrochloride, (S)-; Nogitecan hydrochloride (JAN); Topotecan hydrochloride (USAN); SKF 104864A (Hydrochloride);NSC 609669 (Hydrochloride); CHEMBL1607; Hycamptamine hydrochloride; NOGITECAN HYDROCHLORIDE [JAN]; (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;hydrochloride; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione hydrochloride; 1067286-75-2; SMR000466344; CAS-119413-54-6; SK&F-S-104864A; DRG-0288; 1,4-Di[4-(3-phenoxypropoxy)-2-butynyl]piperazine; Evotropin; UNII-956S425ZCY; s1231; Potactasol (TN); SKF 104864A; Topotecan Hydrocholoride; SCHEMBL7247; SCHEMBL7248; Hycamtin (TN) (GlaxoSmith); MLS000759456; MLS001401447; SPECTRUM1505820; orb1183600; orb1226834; orb1309516; SCHEMBL29375999; CHEBI:232548; GLXC-05536; HMS1922H22; HY-13768AR; MSK157243A; Pharmakon1600-01505820; SKF-S 104864-A; TOPOTECAN HYDROCHLORIDE [MI]; Tox21_111478; CCG-37460; EBC-11244; HY-13768A; NCGC00014925; NCI609699; NK-211; NSC759263; Topotecan (hydrochloride) (Standard); AKOS015900415; Tox21_111478_1; AC-1551; CS-1498; FT28329; KS-1410; NC00177; NSC 759263; NSC-609669; TOPOTECAN HYDROCHLORIDE [MART.]; TOPOTECAN HYDROCHLORIDE [VANDF]; TOPOTECAN HYDROCHLORIDE [USP-RS]; TOPOTECAN HYDROCHLORIDE [WHO-DD]; NCGC00014925-06; NCGC00095189-02; NCGC00095189-03; SY013198; SW197557-5; TOPOTECAN HYDROCHLORIDE [ORANGE BOOK]; D02168; E-89/001; 9-Dimethylaminomethyl-10-hydroxycamptothecin, HCl salt; Q27271753; 9-[(DIMETHYLAMINO)METHYL]-10-HYDROXY-(20S)-CAMPTOTHECIN, HCL; (4S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4',6-7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONE; (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4',6-7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochlorid e; (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione--hydrogen chloride (1/1); (4S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONEHYDROCHLORIDE (1:1); (S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dionehydrochloride; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-Pyrano[3 inverted exclamation mark ,4 inverted exclamation mark :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione Hydrochloride; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONEMONOHYDROCHLORIDE; 10-[(Dimethylamino)methyl]-4S-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, HCl; 1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, monohydrochloride, (4S)-同义词
含有Topotecan Hydrochloride的产品
토포칸주(토포테칸염산염)하이캄틴주4밀리그램(토포테칸염산염)ハイカムチン注射用1.1mgハイカムチン点滴静注液1mg/1mLTOPOTECAN HOSPIRA 4 MG/4 ML CONCENTRADO PARA SOLUCION PARA PERFUSIONHYCAMTIN 4 mg POLVO CONCENTRADO PARA SOLUCION PARA PERFUSIONHYCAMTIN 1 mg CAPSULAS DURASHYCAMTIN 0,25 mg CAPSULAS DURASTOPOTECANE ACCORD 1 mg/ml, solution à diluer pour perfusionTOPOTECAN HOSPIRA 4 mg/4ml, solution à diluer pour perfusionHYCAMTIN 4 mg, poudre pour solution à diluer pour perfusionHYCAMTIN 1 mg, gélule
第 1/3 页
销售Topotecan Hydrochloride的公司
한국
한국유나이티드제약(주)Republic of Korea삼일
삼일제약(주)Republic of KoreaCI
CiplaIndiaHD
Hangzhou Dingyan Chem Co., LtdChinaSX
Sichuan Xieli Pharmaceutical Co., Ltd.ChinaBE
BEIJING EARLYBIRD INDUSTRY DEVELOPMENT CO.,LTD.ChinaNP
Novartis Pharmaceuticals CorporationSwitzerlandPE
PFIZER EUROPE MA EEIGBelgium第 1/2 页